Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease DOI Creative Commons
Constanze Depp, Ting Sun, Andrew Octavian Sasmita

и другие.

Nature, Год журнала: 2023, Номер 618(7964), С. 349 - 357

Опубликована: Май 31, 2023

The incidence of Alzheimer's disease (AD), the leading cause dementia, increases rapidly with age, but why age constitutes main risk factor is still poorly understood. Brain ageing affects oligodendrocytes and structural integrity myelin sheaths1, latter which associated secondary neuroinflammation2,3. As support axonal energy metabolism neuronal health4-7, we hypothesized that loss could be an upstream for amyloid-β (Aβ) deposition, central neuropathological hallmark AD. Here identify genetic pathways dysfunction demyelinating injuries as potent drivers amyloid deposition in mouse models Mechanistically, causes accumulation Aβ-producing machinery within swellings cleavage cortical precursor protein. Suprisingly, AD mice dysfunctional lack plaque-corralling microglia despite overall increase their numbers. Bulk single-cell transcriptomics defects show there a concomitant induction highly similar distinct disease-associated signatures specific to damage plaques, respectively. Despite successful induction, (DAM) usually clear plaques are apparently distracted nearby damage. Our data suggest working model whereby age-dependent promote Aβ plaque formation directly indirectly therefore factor. Improving oligodendrocyte health promising target delay development slow progression

Язык: Английский

Alzheimer's disease DOI
Philip Scheltens, Bart De Strooper, Miia Kivipelto

и другие.

The Lancet, Год журнала: 2021, Номер 397(10284), С. 1577 - 1590

Опубликована: Март 2, 2021

Язык: Английский

Процитировано

3039

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies DOI Creative Commons
Justin M. Long, David M. Holtzman

Cell, Год журнала: 2019, Номер 179(2), С. 312 - 339

Опубликована: Сен. 26, 2019

Язык: Английский

Процитировано

2351

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies DOI
Yu Yamazaki, Na Zhao, Thomas R. Caulfield

и другие.

Nature Reviews Neurology, Год журнала: 2019, Номер 15(9), С. 501 - 518

Опубликована: Июль 31, 2019

Язык: Английский

Процитировано

1036

Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease DOI Creative Commons
Wei-Ting Chen,

Ashley Lu,

Katleen Craessaerts

и другие.

Cell, Год журнала: 2020, Номер 182(4), С. 976 - 991.e19

Опубликована: Июль 22, 2020

Язык: Английский

Процитировано

708

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases DOI Creative Commons
Theodore S. Kapellos, Lorenzo Bonaguro, Ioanna D. Gemünd

и другие.

Frontiers in Immunology, Год журнала: 2019, Номер 10

Опубликована: Авг. 30, 2019

Human monocytes are divided in three major populations; classical (CD14+CD16-), non-classical (CD14dimCD16+), and intermediate (CD14+CD16+). Each of these subsets is distinguished from each other by the expression distinct surface markers their functions homeostasis disease. In this review, we discuss most up-to-date phenotypic classification human that has been greatly aided application novel single-cell transcriptomic mass cytometry technologies. Furthermore, shed light on role plastic immune cells already recognized emerging chronic diseases, such as obesity, atherosclerosis, obstructive pulmonary disease, lung fibrosis, cancer, Alzheimer's Our aim to provide an insight into contribution progression diseases highlight candidacy potential therapeutic cell targets.

Язык: Английский

Процитировано

693

Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model DOI Creative Commons

Elizabeth E. Spangenberg,

Paul Severson, Lindsay A. Hohsfield

и другие.

Nature Communications, Год журнала: 2019, Номер 10(1)

Опубликована: Авг. 21, 2019

Abstract Many risk genes for the development of Alzheimer’s disease (AD) are exclusively or highly expressed in myeloid cells. Microglia dependent on colony-stimulating factor 1 receptor (CSF1R) signaling their survival. We designed and synthesized a selective brain-penetrant CSF1R inhibitor (PLX5622) allowing extended specific microglial elimination, preceding during pathology development. find that 5xFAD mouse model AD, plaques fail to form parenchymal space following depletion, except areas containing surviving microglia. Instead, Aβ deposits cortical blood vessels reminiscent cerebral amyloid angiopathy. Altered gene expression hippocampus is also reversed by absence Transcriptional analyses residual plaque-forming microglia show they exhibit disease-associated profile. Collectively, we describe structure, formulation, efficacy PLX5622, which allows sustained depletion identify roles initiating plaque pathogenesis.

Язык: Английский

Процитировано

654

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches DOI
Alberto Serrano‐Pozo, Sudeshna Das, Bradley T. Hyman

и другие.

The Lancet Neurology, Год журнала: 2020, Номер 20(1), С. 68 - 80

Опубликована: Дек. 17, 2020

Язык: Английский

Процитировано

649

Neuroinflammation as a Common Feature of Neurodegenerative Disorders DOI Creative Commons

Leonardo Guzmán‐Martínez,

Ricardo B. Maccioni, Víctor Andrade

и другие.

Frontiers in Pharmacology, Год журнала: 2019, Номер 10

Опубликована: Сен. 12, 2019

Neurodegenerative diseases share the fact that they derive from altered proteins undergo an unfolding process followed by formation of -structures, and a pathological tendency to self-aggregate in neuronal cells. This is characteristic tau protein Alzheimer´s disease several tauopathies associated unfolding, synuclein Parkinson huntingtin Huntington disease. Usually self-aggregation products are toxic these cells, toxicity spreads all over different brain areas. We have postulated events molecular alterations trigger neurodegenerative disorders. Most interestingly, occur as result neuroinflammatory cascades involving cross-talks between glial cells neurons consequence activation microglia astrocytes. The model we hypothesized for disease, involve damage signals promote activation, NFβ synthesis release proinflammatory cytokines such TNF-, IL1, IL-6, IL-12 affects receptors with overactivation kinases. These patterns can be applied In this context, involvement innate immunity seems major paradigm pathogenesis diseases. important element search potential therapeutic approaches

Язык: Английский

Процитировано

588

TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge DOI Creative Commons

Alicia Nugent,

Karin Lin,

Bettina van Lengerich

и другие.

Neuron, Год журнала: 2020, Номер 105(5), С. 837 - 854.e9

Опубликована: Янв. 2, 2020

Язык: Английский

Процитировано

514

Microglia: Immune and non-immune functions DOI
Katharina Borst, Anaëlle Dumas, Marco Prinz

и другие.

Immunity, Год журнала: 2021, Номер 54(10), С. 2194 - 2208

Опубликована: Окт. 1, 2021

Язык: Английский

Процитировано

437